Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nihon Chouzai Co's EBIT per Share for the
three
months ended in Sep. 2025 was 円22.05.
Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2025 was 円75.00.
During the past 12 months, the average EBIT per Share Growth Rate of Nihon Chouzai Co was -33.70% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -1.70% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -1.30% per year.
During the past 10 years, the average EBIT per Share Growth Rate was -1.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Nihon Chouzai Co's EBIT per Share or its related term are showing as below:
TSE:3341'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -15.5 Med: 0.25 Max: 47.1
Current: -1.7
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Nihon Chouzai Co was 47.10% per year. The lowest was -15.50% per year. And the median was 0.25% per year.
TSE:3341's 3-Year EBIT Growth Rate is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 12.05
vs TSE:3341: -1.70
Nihon Chouzai Co (TSE:3341) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Nihon Chouzai Co EBIT per Share Related Terms
Nihon Chouzai Co EBIT per Share Historical Data
* Premium members only.
The historical data trend for Nihon Chouzai Co's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円75.00
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nihon Chouzai Co (TSE:3341) has a EBIT per Share of 円75.00 as of Sep. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Nihon Chouzai Co and its competitors.
Is Nihon Chouzai Co's EBIT per Share too high?
Nihon Chouzai Co's current EBIT per Share is 円75.00. Overall, Nihon Chouzai Co has a GF Score™ of 51/100, reflecting its overall financial health beyond just this single metric.
How does Nihon Chouzai Co's EBIT per Share compare to competitors?
Nihon Chouzai Co's EBIT per Share of 円75.00 can be compared against companies in the Healthcare Providers & Services industry. The industry median EBIT per Share is 12.05. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 12.05, based on 526 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Nihon Chouzai Co and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 12.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nihon Chouzai Co's current EBIT per Share is 円75.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nihon Chouzai Co stock overvalued right now?
Nihon Chouzai Co (TSE:3341) has a current EBIT per Share of 円75.00. The stock's GF Value™ is 円1,563.20, compared to a current price of 円3,925.00 — trading 151.1% above its estimated fair value. The current EBIT per Share is 円75.00. Nihon Chouzai Co's overall GF Score™ is 51/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Nihon Chouzai Co (TSE:3341), the current EBIT per Share is 円75.00 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nihon Chouzai Co (TSE:3341) Overvalued in 2026?
Based on GuruFocus' analysis, Nihon Chouzai Co stock appears to be overvalued.
The current stock price of 円3,925.00 is trading 151.1% above its estimated GF Value™ of 円1,563.20.
Key valuation signals for TSE:3341:
EBIT per Share: 円75.00
GF Value™: 円1,563.20 vs. price of 円3,925.00 (151.1% above fair value)
No single metric tells the full story. See the TSE:3341 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nihon Chouzai Co Ltd operates in the pharmaceutical industry. The company is organized into segments: Pharmacy, Pharmaceutical Manufacturing and Sales, and Healthcare Staffing Services and operates mainly from Japan. Through its operating segments, the firm manages a chain of pharmacies nationwide, manufactures and sells generic drugs, and provides staffing services that are specialized in pharmacy.
51GF Score
Get the complete analysis for TSE:3341
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3341 has been successfully added to your 
